Literature DB >> 21636892

Contribution of the 80s loop of HIV-1 protease to the multidrug-resistance mechanism: crystallographic study of MDR769 HIV-1 protease variants.

Ravikiran S Yedidi1, Georghe Proteasa, Jorge L Martinez, John F Vickrey, Philip D Martin, Zdzislaw Wawrzak, Zhigang Liu, Iulia A Kovari, Ladislau C Kovari.   

Abstract

The flexible flaps and the 80s loops (Pro79-Ile84) of HIV-1 protease are crucial in inhibitor binding. Previously, it was reported that the crystal structure of multidrug-resistant 769 (MDR769) HIV-1 protease shows a wide-open conformation of the flaps owing to conformational rigidity acquired by the accumulation of mutations. In the current study, the effect of mutations on the conformation of the 80s loop of MDR769 HIV-1 protease variants is reported. Alternate conformations of Pro81 (proline switch) with a root-mean-square deviation of 3-4.8 Å in the C(α) atoms of the I10V mutant and a side chain with a `flipped-out' conformation in the A82F mutant cause distortion in the S1/S1' binding pockets that affects inhibitor binding. The A82S and A82T mutants show local changes in the electrostatics of inhibitor binding owing to the mutation from nonpolar to polar residues. In summary, the crystallographic studies of four variants of MDR769 HIV-1 protease presented in this article provide new insights towards understanding the drug-resistance mechanism as well as a basis for design of future protease inhibitors with enhanced potency.
© 2011 International Union of Crystallography

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21636892      PMCID: PMC3107050          DOI: 10.1107/S0907444911011541

Source DB:  PubMed          Journal:  Acta Crystallogr D Biol Crystallogr        ISSN: 0907-4449


  27 in total

1.  Effects of remote mutation on the autolysis of HIV-1 PR: X-ray and NMR investigations.

Authors:  Mukesh Kumar; K K Kannan; M V Hosur; Neel S Bhavesh; Amarnath Chatterjee; Rohit Mittal; R V Hosur
Journal:  Biochem Biophys Res Commun       Date:  2002-06-07       Impact factor: 3.575

2.  Automated refinement of protein models.

Authors:  V S Lamzin; K S Wilson
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1993-01-01

3.  Stereochemical quality of protein structure coordinates.

Authors:  A L Morris; M W MacArthur; E G Hutchinson; J M Thornton
Journal:  Proteins       Date:  1992-04

4.  Mechanism of drug resistance revealed by the crystal structure of the unliganded HIV-1 protease with F53L mutation.

Authors:  Fengling Liu; Andrey Y Kovalevsky; John M Louis; Peter I Boross; Yuan-Fang Wang; Robert W Harrison; Irene T Weber
Journal:  J Mol Biol       Date:  2006-03-20       Impact factor: 5.469

5.  1.9 A x-ray study shows closed flap conformation in crystals of tethered HIV-1 PR.

Authors:  B Pillai; K K Kannan; M V Hosur
Journal:  Proteins       Date:  2001-04-01

6.  Solution structure of the mature HIV-1 protease monomer: insight into the tertiary fold and stability of a precursor.

Authors:  Rieko Ishima; Dennis A Torchia; Shannon M Lynch; Angela M Gronenborn; John M Louis
Journal:  J Biol Chem       Date:  2003-08-21       Impact factor: 5.157

7.  Clarifying allosteric control of flap conformations in the 1TW7 crystal structure of HIV-1 protease.

Authors:  Katrina W Lexa; Kelly L Damm; Jerome J Quintero; Jason E Gestwicki; Heather A Carlson
Journal:  Proteins       Date:  2009-03

Review 8.  The integration of macromolecular diffraction data.

Authors:  Andrew G W Leslie
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2005-12-14

Review 9.  Scaling and assessment of data quality.

Authors:  Philip Evans
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2005-12-14

10.  Overview of the CCP4 suite and current developments.

Authors:  Martyn D Winn; Charles C Ballard; Kevin D Cowtan; Eleanor J Dodson; Paul Emsley; Phil R Evans; Ronan M Keegan; Eugene B Krissinel; Andrew G W Leslie; Airlie McCoy; Stuart J McNicholas; Garib N Murshudov; Navraj S Pannu; Elizabeth A Potterton; Harold R Powell; Randy J Read; Alexei Vagin; Keith S Wilson
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2011-03-18
View more
  17 in total

1.  A conserved hydrogen-bonding network of P2 bis-tetrahydrofuran-containing HIV-1 protease inhibitors (PIs) with a protease active-site amino acid backbone aids in their activity against PI-resistant HIV.

Authors:  Ravikiran S Yedidi; Harisha Garimella; Manabu Aoki; Hiromi Aoki-Ogata; Darshan V Desai; Simon B Chang; David A Davis; W Sean Fyvie; Joshua D Kaufman; David W Smith; Debananda Das; Paul T Wingfield; Kenji Maeda; Arun K Ghosh; Hiroaki Mitsuya
Journal:  Antimicrob Agents Chemother       Date:  2014-04-21       Impact factor: 5.191

Review 2.  Highly resistant HIV-1 proteases and strategies for their inhibition.

Authors:  Irene T Weber; Daniel W Kneller; Andres Wong-Sam
Journal:  Future Med Chem       Date:  2015       Impact factor: 3.808

3.  Potent antiviral HIV-1 protease inhibitor combats highly drug resistant mutant PR20.

Authors:  Daniel W Kneller; Johnson Agniswamy; Arun K Ghosh; Irene T Weber
Journal:  Biochem Biophys Res Commun       Date:  2019-08-29       Impact factor: 3.575

4.  Crystallographic study of multi-drug resistant HIV-1 protease lopinavir complex: mechanism of drug recognition and resistance.

Authors:  Zhigang Liu; Ravikiran S Yedidi; Yong Wang; Tamaria G Dewdney; Samuel J Reiter; Joseph S Brunzelle; Iulia A Kovari; Ladislau C Kovari
Journal:  Biochem Biophys Res Commun       Date:  2013-06-18       Impact factor: 3.575

5.  Crystal structures of multidrug-resistant HIV-1 protease in complex with two potent anti-malarial compounds.

Authors:  Ravikiran S Yedidi; Zhigang Liu; Yong Wang; Joseph S Brunzelle; Iulia A Kovari; Patrick M Woster; Ladislau C Kovari; Deepak Gupta
Journal:  Biochem Biophys Res Commun       Date:  2012-03-24       Impact factor: 3.575

6.  The higher barrier of darunavir and tipranavir resistance for HIV-1 protease.

Authors:  Yong Wang; Zhigang Liu; Joseph S Brunzelle; Iulia A Kovari; Tamaria G Dewdney; Samuel J Reiter; Ladislau C Kovari
Journal:  Biochem Biophys Res Commun       Date:  2011-08-17       Impact factor: 3.575

7.  P1 and P1' para-fluoro phenyl groups show enhanced binding and favorable predicted pharmacological properties: structure-based virtual screening of extended lopinavir analogs against multi-drug resistant HIV-1 protease.

Authors:  Ravikiran S Yedidi; Zhigang Liu; Iulia A Kovari; Patrick M Woster; Ladislau C Kovari
Journal:  J Mol Graph Model       Date:  2013-11-01       Impact factor: 2.518

8.  P2' benzene carboxylic acid moiety is associated with decrease in cellular uptake: evaluation of novel nonpeptidic HIV-1 protease inhibitors containing P2 bis-tetrahydrofuran moiety.

Authors:  Ravikiran S Yedidi; Kenji Maeda; W Sean Fyvie; Melinda Steffey; David A Davis; Ira Palmer; Manabu Aoki; Joshua D Kaufman; Stephen J Stahl; Harisha Garimella; Debananda Das; Paul T Wingfield; Arun K Ghosh; Hiroaki Mitsuya
Journal:  Antimicrob Agents Chemother       Date:  2013-07-22       Impact factor: 5.191

9.  A multi-drug resistant HIV-1 protease is resistant to the dimerization inhibitory activity of TLF-PafF.

Authors:  Ravikiran S Yedidi; Gheorghe Proteasa; Philip D Martin; Zhigang Liu; John F Vickrey; Iulia A Kovari; Ladislau C Kovari
Journal:  J Mol Graph Model       Date:  2014-07-04       Impact factor: 2.518

10.  Design, synthesis and evaluation of a potent substrate analog inhibitor identified by scanning Ala/Phe mutagenesis, mimicking substrate co-evolution, against multidrug-resistant HIV-1 protease.

Authors:  Ravikiran S Yedidi; Joseck M Muhuhi; Zhigang Liu; Krisztina Z Bencze; Kyriacos Koupparis; Carrie E O'Connor; Iulia A Kovari; Mark R Spaller; Ladislau C Kovari
Journal:  Biochem Biophys Res Commun       Date:  2013-08-03       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.